With Eris on the rise, US CDC sees no major shift in COVID variants
Send a link to a friend
[August 10, 2023]
(Reuters) - Currently spreading COVID-19 variants such as EG.5,
or Eris, do not represent a major shift and updated vaccines in
September will offer protection, the director of the U.S. Centers for
Disease Control and Prevention said on Wednesday.
"Right now, what we're seeing with the changes in the viruses, they're
still susceptible to our vaccine, they're still susceptible to our
medicines, they're still picked up by the tests," Director Dr. Mandy
Cohen said in an interview on former Biden administration adviser Andy
Slavitt's "In the Bubble" podcast. "We're seeing small changes that are
what I would call subtypes of what we've seen before."
Updated vaccines should be available by mid- to late September, she
said.
COVID-19 vaccine manufacturers have created new versions of their
vaccine, which were updated to target the so-called XBB.1.5 subvariant
that was dominant earlier this year in order to more closely resemble
the circulating virus.
"We anticipate that they are going to be available for most folks by the
third or fourth week of September," Cohen said. The vaccines still need
to be authorized by the U.S. Food and Drug Administration and the CDC
needs to make its recommendations, she said.
[to top of second column]
|
A general view of the Centers for
Disease Control and Prevention (CDC) headquarters in Atlanta,
Georgia September 30, 2014. REUTERS/Tami Chappell/File Photo
"We are likely to see this as a
recommendation as an annual COVID shot just like we have an annual
flu shot," she said.
Pfizer/BioNTech SE, Moderna and Novavax have all said they expect to
have supplies of the updated vaccine ready for the roll out this
autumn.
On Wednesday, the World Health Organization classified the EG.5
coronavirus strain, circulating in the United States and China, as a
"variant of interest" but said it did not seem to pose more of a
threat to public health than other variants. Eris is the
fasting-growing COVID-19 subvariant in the U.S., estimated to be
responsible for around 17% of current COVID cases, according to the
CDC.
(Reporting by Michael Erman in New York; Editing by Lisa Shumaker)
[© 2023 Thomson Reuters. All rights
reserved.]This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |